US health regulator finds Silvassa unit non-compliant with CGMP: Ipca Labs
Posted by
www.biotecnika.org
The company said that since this manufacturing facility is already
under USFDA import alert and presently not doing any US business, this
will have no impact on company's current on-going business activities.
The USFDA inspection of its Piparia (Silvassa) formulations
manufacturing unit in August resulted in three observations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-health-regulator-finds-silvassa-unit-non-compliant-with-cgmp-ipca-labs/articleshow/72237734.cms
Subscribe to:
Post Comments (Atom)
Post a Comment